We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Improved Method for DNA Payloads Delivered into Cells

By LabMedica International staff writers
Posted on 04 Aug 2010
Chemical engineers have developed a new technique that greatly enhances the delivery of DNA payloads into cells. More...


Dr. Chang Lu and his research group from Virginia Polytechnic Institute and State University (Virginia Tech; Blacksburg, USA) have published their findings in the July 8, 2010, issue of the journal Nature and in an upcoming issue of Lab on a Chip. Dr. Lu's ultimate goal is to apply this technique to generate genetically modified cells for cancer immunotherapy, stem cell therapy and tissue regeneration.

One of the most widely used physical techniques to deliver genes into cells "is incredibly inefficient because only a small fraction of a cell's total membrane surface can be permeated,” stated Dr. Lu, an associate professor of chemical engineering at Virginia Tech. The method Lu is referring to is called electroporation, a phenomenon known for years that increases the permeability of a cell by applying an electric field to generate tiny pores in the membrane of cells.

Dr. Lu called the process "a new spin on DNA delivery.” He clarified the process: "Conventional electroporation methods deliver DNA only within a very small portion of the cell surface, determined by the physics governing the interaction between an electric field and a cell. Our method enables uniform DNA delivery over the entire cell surface, which is the first time we are aware that this has been demonstrated. The result is a greatly enhanced transfer of the genetic material.”

Dr. Lu reported that his new approach harnesses "hydrodynamic effects that uniquely occur when fluids flow along curved paths. Flow under these conditions is known to generate vortices. Cells carried by such flow experience rotation and spinning that help expose the majority area of its surface to the electric field.” Having the gene delivery done by flows in curved paths is critical in the gene delivery process as opposed to the traditionally used electroporation in static solution or in straight channels. "A spiral-shaped channel design yields a two-fold increase than a straight channel and an even larger factor compared to in static solution,” he added.

By using fluorescence microscopy, the engineers were able to map the area on the cell surface that was subjected to electroporation, and determine the extent of the DNA entry into the cell. Dr. Lu explained the conventional delivery using a cuvette-type of device with static cell suspension produces DNA delivery restricted to a narrow zone on the cell surface. However, when electroporation is applied to flowing cells in a spiral or curved channel, the images "appear dramatically different with the DNA delivery uniformly distributed over the entire cell surface.”

Dr. Lu's group plans to make larger devices to exploit this phenomenon and apply them to large volume gene delivery in the near future.

Related Links:

Virginia Polytechnic Institute and State University




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.